Nagpur: Food and Medicine Administration (FDA), Nagpur, has urged medical and oxygen officers on government charges and private health care sectors throughout Wardha, Nagpur, Bhandara, Gondia, Chandrapur and Gadchiroli in East Vidarbha to maintain their liquid medical oxygen storage.
Tanks and cylinders are ready to meet any requirements that might arise because of the third wave.
In accordance with the FDA authority, the cumulative storage capacity of various oxygen facilities in six districts is around 729 kilo-liters, with a production of 151 metric tons (MT) and 101.9 MT recycling capacity.
In Nagpur Regency, the total storage capacity of various facilities is 515 kilo-liters, with a production of 136 MT and 71.2 MT recycling capacity.
FDA and district health officials felt that seeing trends observed with Omicron and the views of experts, oxygen requirements during the current surge may not flood the available capacity as carried out during the second wave driven by Delta.
Commissioner with FDA Viraj Paunikar in a letter last week has asked officials related to the health care facilities of the government and private Covid Hospital to begin preparing to meet medical oxygen needs if inpatient occur.
Paunikar has also requested oxygen charges from government and private hospitals to share their oxygen availability and storage in the WhatsApp group to be monitored by officials from the FDA, the Department of Health and the District Administration.
FDA officials said the availability of oxygen and balance sheet storage in different places, including in facilities made in government-owned hospitals and private producers, is being monitored every day to ensure supply and distribution capacity is still updated with officials and decisions to make authority.
“We have notified oxygen on charges and medical officers to keep the FDA update about their oxygen status regularly,” said Paunikar.
Last week, the FDA also drives three days, as part of the exercise throughout the state, to visit private liquid medical oxygen manufacturing factories, refilling and air separation units to ensure their production infrastructure, the manufacturing process and supply capacity of functional and functional .
well maintained.
The final report of the visit will be sent to the FDA headquarters in Mumbai.
The FDA Asst Commissioner PM Ballal said that it was done to perfect the coordination between different institutions and maintain an update of the oxygen production unit and its functional capacity.
“We have carefully monitored the production plant, holding together meetings and trying to sort out the problem.
Likewise, we have notified the FDA senior authority about our observations,” he said.